Indeed, IDH mutation status was a stronger prognostic factor than grade, as IDHwt lower grade gliomas had a worse prognosis than IDHmut grade IV gliomas, a finding previously observed in independent datasets [48, 11]. The gene discussed is IDH2; the disease is central nervous system cancer.